N@N

AKS, ESI, STJ, CHKP, GSK, CP Expected To Be Higher Leading Up To Next Earnings Releases

^{Published on 2009-07-17 08:03:49, Last Modified on 2010-12-22 14:31:43 - WOPRAI}
 

July 17, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and July/August earnings reports. AK Steel (NYSE: AKS), ITT Educational Services (NYSE: ESI), St. Jude Medical (NYSE: STJ), Check Point Software (NASDAQ: CHKP), GlaxoSmithKline (NYSE: GSK) and Canadian Pacific Railway (NYSE: CP) are all expected to be higher leading up to their next earnings release. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act before its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go higher leading up to their next earnings release:

Symbol Company # of Reports Quarter Release Date

AKS AK Steel Holding Corp. 12 quarters Q2 7/21/2009

ESI ITT Educational Servi 12 quarters Q2 7/23/2009

STJ St. Jude Medical, Inc. 12 quarters Q2 7/22/2009

CHKP Check Point Software 12 quarters Q2 7/28/2009

GSK GlaxoSmithKline plc July earnings Q2 7/22/2009

CP Canadian Pacific Rail 12 quarters Q2 7/30/2009

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event. because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

AK Steel Holding Corporation (NYSE: AKS), through its subsidiaries, produces flat-rolled carbon, stainless, and electrical steels, and tubular products primarily in the United States and internationally. It manufactures flat-rolled carbon steels, including coated, cold-rolled, and hot-rolled products; and specialty stainless and electrical steels that are sold in slab, hot band, and sheet and strip forms. The company also involves in finishing flat-rolled carbon and stainless steel into welded steel tubing, which is used in the automotive, large truck, and construction markets; and trades in steel and steel products in Europe. It sells flat-rolled carbon steel products primarily to automotive manufacturers; and to customers in the infrastructure and manufacturing markets consisting of manufacturers of appliances, electrical transmission, heating, ventilation, and air conditioning. The company also sells its coated, cold rolled, and hot rolled carbon steel products to distributors, service centers, and converters. AK Steel Holding sells its stainless steel products primarily to manufacturers and their suppliers in the automotive industry; manufacturers of food handling, chemical processing, pollution control, and medical and health equipment; and distributors and service centers; and electrical steels to manufacturers of power transmission and distribution transformers, and electrical motors and generators. The company was founded in 1993 and is headquartered in West Chester, Ohio.

ITT Educational Services, Inc. (NYSE: ESI) provides postsecondary degree programs in the United States. The company offers master, bachelor, associate, and career focused degree programs in various fields, such as information technology, electronics technology, drafting and design, business, criminal justice, and health sciences. Its information technology programs include network administration, technical support, network technology, and systems technology; and electronics technology programs include electronics product design and fabrication, communications, computer technology, industrial electronics, instrumentation, and telecommunications. The companya�s drafting and design programs comprise computer aided manufacturing, electrical and electronics drafting, mechanical drafting, architectural and construction drafting, civil drafting, interior design, landscape architecture, and multimedia communications; business programs include accounting, financial services, marketing and advertising, and manufacturing; and criminal justice programs consist of corrections, security and policing, investigations, and cyber security. As of December 31, 2008, it offered degree programs to approximately 62,000 students, and had 105 institutes and 9 learning sites located in 37 states. The company was founded in 1946 and is headquartered in Carmel, Indiana.

St. Jude Medical, Inc. (NYSE: STJ) develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantable cardioverter defibrillator systems to provide therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy devices to treat heart failure patients; pacemakers to help people whose hearts beat too slowly or who suffer from other cardiac arrhythmias; and leads, which connect devices to the heart and carry the electrical impulses to the heart and information from the heart back to the device. The Cardiovascular segment provides mechanical and tissue replacement heart valves, as well as heart valve repair products. It also offers disposable interventional devices, including vascular closure devices, percutaneous catheter introducers, diagnostic guidewires, and temporary bipolar pacing catheters. The Atrial Fibrillation segment provides a system of products for access, diagnosis, visualization, and ablation that assist physicians in diagnosing and treating various irregular heart rhythms used in the electrophysiology lab and cardiac surgery. It offers electrophysiology introducers and catheters, cardiac mapping, navigation and recording systems, and ablation systems. The Neuromodulation segment offers a range of neurostimulation systems, including rechargeable implantable pulse generators, conventional implantable pulse generators, and radio frequency powered systems. St. Jude Medical markets its products through a direct sales force and independent distributors. The company was founded in 1976 and is headquartered in St. Paul, Minnesota.

Check Point Software Technologies Ltd. (NASDAQ: CHKP), together with its subsidiaries, develops, markets, and supports a range of software, and combined hardware and software products and services for information technology security worldwide. The company offers its customers a portfolio of network and gateway security solutions, data and endpoint security solutions, and management solutions. Its solutions operate under a unified security architecture that enables end-to-end security with a single line of unified security gateways and enables a single agent for various endpoint securities. The companya�s network and gateway security solutions include Firewall that inspects traffic as it passes through security gateways; intrusion prevention technologies; virtual private networks (VPNs); content screening; messaging security; Web-based communications; security acceleration; and virtualization. Its data and endpoint security technologies include Personal Firewall; Data Protection; Remote Access VPNs; and Anti-Malware. The companya�s security management solutions include centralized policy management, which enables in defining various aspects of the security policy; provisioning tools that allow the daily deployment and removal of individual entities, such as new gateways, users, and devices; monitoring tools; auditing tools; and security information and event management. It sells its products to enterprises, service providers, small and medium-sized businesses, and consumers through a network of channel partners, including distributors, resellers, value-added resellers, system integrators, and managed services providers. The company has strategic relationships with Crossbeam Systems, Inc.; Dell, Inc.; Hewlett-Packard Co.; IBM; Nokia Corporation; Microsoft Corporation; Nortel Networks Corp.; Siemens AG; and Sun Microsystems, Inc. Check Point Software Technologies was founded in 1993 and is headquartered in Tel Aviv, Israel.

GlaxoSmithKline plc (NYSE: GSK), together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical and consumer health-related products. Its Pharmaceuticals segment manufactures prescription drugs and vaccines that are used in various therapeutic areas, including central nervous system, respiratory, anti-viral, anti-bacterial, oncology and emesis, metabolic, cardiovascular, and urogenital. This segment offers Seretide/Advair for asthma and chronic obstructive pulmonary disease (COPD); Avandia for the treatment of type 2 diabetes; Lamictal for epilepsy and bipolar disorder; Wellbutrin, an anti-depressant; Zofran to prevent nausea and vomiting associated with chemotherapy and radiotherapy for cancer; Valtrex for herpes; Coreg for heart disease; and Imigran/Imitrex for migraine and cluster headache. Its products also include Augmentin for the treatment of bacterial infections; Seroxat/Paxil for the treatment of depressive disorder, panic, obsessive compulsive disorder, post traumatic stress disorder, social anxiety disorder, and generalized anxiety disorder; and Flixotide/Flovent, an inhaled steroid for the treatment of inflammation associated with asthma and COPD. The companya�s Consumer Healthcare segment offers over-the-counter medicines, oral care, and nutritional healthcare products. Its products comprise Lucozade energy and sports drinks; Aquafresh and Sensodyne toothpastes and mouthwashes; Aquafresh and Dr Best toothbrushes; Panadol, a paracetamol/acetaminophen analgesic; Horlicks, a milk-based malted food and chocolate drinks; and Ribena, a blackcurrant juice-based drink. GlaxoSmithKline operates in the United States, Europe, Japan, the Asia Pacific, the Middle East, Latin America, Africa, and Canada. It has agreements with Anacor Pharmaceuticals, Inc.; Oncomed Pharmaceuticals, Inc.; Santaris Pharma A/S; and Targacept, Inc. The company was founded in 1935 and is headquartered in Uxbridge, the United Kingdom.

Canadian Pacific Railway Limited (NYSE: CP), through its subsidiaries, operates a transcontinental railway in Canada and the United States. It offers rail and intermodal freight transportation services over approximately 15,500-mile railway network serving the principal business centers of Canada, including Montreal, Quebec, Vancouver, British Colombia; and the midwest and northeast regions of the United States. The company transports bulk commodities, including, grain, coal, sulphur, and fertilizers; merchandise freight that consist of finished vehicles and automotive parts; and intermodal traffic, which includes time-sensitive retail goods, as well as forest, industrial, and consumer products. Canadian Pacific Railway Limited was founded in 1881 and is based in Calgary, Canada. Canadian Pacific Railway Limited (TSX:CP) operates independently of Canadian Pacific Limited as of October 01, 2001.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

One example from the SqueezeTrigger database is approximately 2.5 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641